Bnan Razoky, MD
Geriatric Medicine · Troy, MINPI 1942317789
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 383 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 383 payments — averaging $29.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Pfizer$1K
- Amgen$1K
- AstraZeneca$1K
- Lilly USA, LLC$728
- Boehringer Ingelheim$681
- plus $5K from 26 others
What the payments were for
- Speaking & faculty fees$2062%
- Food & beverage$11,16198%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 74 | $1,915 |
| Pfizer | 55 | $1,163 |
| Amgen(2 entities) | 34 | $1,150 |
| AstraZeneca | 25 | $1,048 |
| Lilly USA, LLC | 18 | $728 |
| Boehringer Ingelheim | 13 | $681 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 28 | $656 |
| GSK | 9 | $537 |
| Johnson & Johnson | 15 | $388 |
| Amarin Pharma, Inc. | 22 | $385 |
| Exact Sciences | 12 | $303 |
| Merck | 5 | $261 |
| Sumitomo Pharma America, Inc. | 8 | $255 |
| Corcept Therapeutics | 4 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $208 |
| Shield Therapeutics Inc | 11 | $200 |
| Dexcom, Inc. | 5 | $180 |
| Novartis | 9 | $161 |
| Biohaven Pharmaceuticals, Inc. | 3 | $157 |
| Astellas Pharma US Inc | 2 | $150 |
| Phathom Pharmaceuticals, Inc. | 2 | $142 |
| Redhill Biopharma Inc. | 5 | $127 |
| Amneal Pharmaceuticals LLC | 1 | $95 |
| Sunovion Pharmaceuticals Inc. | 4 | $66 |
| E.r. Squibb & Sons, L.L.C. | 4 | $54 |
| Kowa Pharmaceuticals America, Inc. | 3 | $36 |
| Pharming Healthcare, Inc. | 1 | $30 |
| Abiomed | 1 | $18 |
| Gilead | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,367 in reported general payments places this provider in the 95th percentile of 168 geriatric medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 285 | $246,635 |
| EliquisApixaban | 208 | $190,679 |
| OzempicSemaglutide | 159 | $188,859 |
| TradjentaLinagliptin | 95 | $77,240 |
| FarxigaDapagliflozin Propanediol | 76 | $70,631 |
| XareltoRivaroxaban | 52 | $58,315 |
| GemtesaVibegron | 86 | $56,556 |
| JanuviaSitagliptin Phosphate | 75 | $55,079 |
| RybelsusSemaglutide | 33 | $43,347 |
| MounjaroTirzepatide | 33 | $36,120 |
| LinzessLinaclotide | 48 | $31,885 |
| EntrestoSacubitril/Valsartan | 31 | $31,373 |
| GlyxambiEmpagliflozin/Linagliptin | 31 | $30,483 |
| Repatha SureclickEvolocumab | 40 | $30,023 |
| VascepaIcosapent Ethyl | 79 | $26,715 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Glyxambi, Stiolto Respimat | $681 | $359,362422 claims |
| Novo NordiskOzempic, Rybelsus | $1,915 | $232,206192 claims |
| PfizerEliquis | $1,163 | $190,679208 claims |
| AstraZenecaFarxiga, Airsupra | $1,048 | $76,43789 claims |
| Johnson & JohnsonXarelto | $388 | $58,31552 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $255 | $56,55686 claims |
| MerckJanuvia | $261 | $55,07975 claims |
| Lilly USA, LLCMounjaro, Trulicity | $728 | $54,45653 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $537 | $36,49766 claims |
| NovartisEntresto | $161 | $31,37331 claims |
| Astellas Pharma US IncMyrbetriq | $150 | $11,44319 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $95 | $3,149374 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 168 geriatric medicine providers in Michigan.
Other geriatric medicine in Troy
- Gerald DaneshvarHamtramck$23K
- Jailan ElayoubiDearborn$20K
- Grace JenqAnn Arbor$12K
- Afriyie GrayGrand Rapids$12K
- Saket SaxenaDetroit$11K
- Randolph SchumacherFlint$9K
- Ronald BarnettLivonia$7K
- Michael BurryLivonia$7K
- Keith TobinLivonia$7K
- Abdullah RaffeeFlint$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.